comparemela.com

Latest Breaking News On - Ono pharmaceutical - Page 7 : comparemela.com

Adagrasib, Cetuximab May Benefit KRASG12c Colorectal Cancer Patients

Adagrasib, Cetuximab May Benefit KRASG12c Colorectal Cancer Patients
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United-states
Texas
American
Redx-pharma
Daiichi-sankyo
Bristol-myers-squibb-medarex
Genentech-roche
Eli-lilly
Scott-kopetz
Navire-pharma
Astrazeneca-medimmune
Lutris-pharma

Adagrasib/Cetuximab Combo Has Activity in KRAS G12C+ Locally Advanced or mCRC

Adagrasib plus cetuximab elicited a 34% objective response rate in patients with previously treated KRAS G12C-mutant advanced colorectal cancer.

Texas
United-states
Houston
San-diego
California
American
Daiichi-sankyo
Bristol-meyers-squibb
Redx-pharma
Eli-lilly
Navire-pharma
Genentech-roche

Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights

Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Boston
Massachusetts
United-states
Jonathan-pappas
Daniel-passeri
Marie-campinell
Cue-biopharma-inc
Linkedin
Nasdaq
Society-for-immunotherapy
Drug-administration
Corporate-communications

Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights

BOSTON, April 08, 2024 Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells, today.

Boston
Massachusetts
United-states
Jonathan-pappas
Marie-campinell
Daniel-passeri
Corporate-communications
Lifesci-communications
Society-for-immunotherapy
Drug-administration
Nasdaq
Cue-biopharma-inc

Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights

Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Massachusetts
United-states
Boston
Marie-campinell
Drug-administration
Linkedin
Corporate-communications
Cue-biopharma-inc
Fourth-quarter
Ono-pharmaceutical
Selective-targeting
Private-securities-litigation-reform-act
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.